Share

All Updates

July 13, 2017
Kansas

ACS CAN Kansas staff set out on a #RoadtriptoPalco to attend Sen. Moran's town hall and to ask him to protect quality, affordable healthcare.

July 13, 2017

This bill would leave patients and those with pre-existing conditions paying more for less coverage and would substantially erode the progress our nation has been trying to make in providing affordable, adequate and meaningful coverage to all Americans.

July 12, 2017
National

The U.S. House Appropriations Committee approved a bill today that would greatly weaken the Food and Drug Administration’s (FDA) oversight of tobacco products. The provision was included in the FY 2018 Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies appropriations bill.

July 12, 2017
National

The House advanced legislation to reauthorize and expand the FDA's user fee programs that maintain a strong partnership between the FDA and industry, with the goal of bringing pharmaceutical drugs and devices to the market, and making them accessible to patients, as expeditiously as possible.

July 12, 2017
California

Martinez, CA – Scores of residents and cancer advocates testified today in favor of an amendment to the Contra Costa County tobacco-control ordinance that will end the sale of flavored tobacco products in unincorporated areas of the county within 1,000 feet of youth-sensitive places such as parks and schools. The

July 11, 2017
West Virginia

“Stand Up for WV and her Children” Ellie’s Story: As told by her grandmother, Lora Wilkerson Ellie, who at only 3-year-old, has been battling cancer since she was 18 months old. She has battled through chemotherapy, multiple surgeries, radiation. neuropathy, and radiation with courage of a grown adult. Ellie relied

July 7, 2017
Colorado

ACS CAN Colorado State and Local Advocacy Accomplishments 2010-2017 2010 As supported by ACS CAN, the Colorado Legislature passed a bill that requires health insurance companies who provide coverage for intravenous chemotherapy to also provide coverage for newer types of oral chemotherapy agents, furthermore requiring that insurance policies